Home · Open Lab · Lot RGX-26-WOLVERINE-661
RGX-26-WOLVERINE-661Superseded
Wolverine · 10 MG · Restorative Research · COA NS-2026-05154

Release test results

99.713%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.06 mg
Related impurities (total)0.287%
Endotoxin<1.0 EU/mg
HPLC retention time4.65 min
MethodHPLC + LC-MS
ResultPass · meets spec
Verify COA at Nordicstar Labs → All certificates

Lot record

CompoundWolverine
Presentation10 MG
Lot numberRGX-26-WOLVERINE-661
COA numberNS-2026-05154
Test date15 Jan 2026
Release date18 Jan 2026
Independent labNordicstar Labs
StatusSuperseded

Wolverine — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-WOLVERINE-103910 MGJul 19, 202699.722%Current
RGX-26-WOLVERINE-104020 MGJul 19, 202699.760%Current
RGX-26-WOLVERINE-76020 MGApr 14, 202699.751%Superseded
RGX-26-WOLVERINE-76110 MGApr 8, 202699.758%Superseded
RGX-26-WOLVERINE-661 this lot10 MGJan 15, 202699.713%Superseded
RGX-26-WOLVERINE-66020 MGJan 13, 202699.568%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →